Choate Investment Advisors Cuts Stock Position in Mettler-Toledo International Inc. (NYSE:MTD)

Choate Investment Advisors decreased its position in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 16.5% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 2,197 shares of the medical instruments supplier’s stock after selling 433 shares during the period. Choate Investment Advisors’ holdings in Mettler-Toledo International were worth $2,688,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Farther Finance Advisors LLC increased its stake in Mettler-Toledo International by 14.3% during the 4th quarter. Farther Finance Advisors LLC now owns 64 shares of the medical instruments supplier’s stock worth $78,000 after buying an additional 8 shares during the period. Huntington National Bank increased its stake in Mettler-Toledo International by 20.0% during the 3rd quarter. Huntington National Bank now owns 54 shares of the medical instruments supplier’s stock worth $81,000 after buying an additional 9 shares during the period. Townsquare Capital LLC increased its stake in Mettler-Toledo International by 2.0% during the 3rd quarter. Townsquare Capital LLC now owns 462 shares of the medical instruments supplier’s stock worth $693,000 after buying an additional 9 shares during the period. M3 Advisory Group LLC increased its stake in Mettler-Toledo International by 5.8% during the 4th quarter. M3 Advisory Group LLC now owns 165 shares of the medical instruments supplier’s stock worth $202,000 after buying an additional 9 shares during the period. Finally, Apollon Wealth Management LLC increased its stake in Mettler-Toledo International by 2.5% during the 4th quarter. Apollon Wealth Management LLC now owns 368 shares of the medical instruments supplier’s stock worth $451,000 after buying an additional 9 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Trading Up 2.4 %

Shares of NYSE:MTD opened at $1,231.32 on Friday. The company has a 50 day moving average of $1,295.03 and a 200-day moving average of $1,317.46. The firm has a market cap of $25.75 billion, a P/E ratio of 30.38, a P/E/G ratio of 3.30 and a beta of 1.15. Mettler-Toledo International Inc. has a twelve month low of $1,142.91 and a twelve month high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, topping analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. Equities research analysts forecast that Mettler-Toledo International Inc. will post 42.71 EPS for the current year.

Insider Transactions at Mettler-Toledo International

In related news, insider Gerry Keller sold 600 shares of the business’s stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total value of $810,804.00. Following the sale, the insider now directly owns 6 shares in the company, valued at $8,108.04. The trade was a 99.01 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Christian Magloth sold 790 shares of the business’s stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the completion of the sale, the insider now owns 734 shares in the company, valued at $964,248.46. The trade was a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.94% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on MTD. Wolfe Research initiated coverage on shares of Mettler-Toledo International in a research note on Friday, December 13th. They set a “peer perform” rating on the stock. Evercore ISI lifted their price target on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a report on Monday, February 10th. Robert W. Baird lifted their price target on shares of Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a “neutral” rating in a report on Monday, February 10th. Citigroup reduced their target price on shares of Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating for the company in a research note on Tuesday, March 4th. Finally, Wells Fargo & Company boosted their target price on shares of Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a research note on Monday, February 10th. One research analyst has rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $1,380.50.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.